Bio-Techne
TECH
562 hedge funds and large institutions have $12.4B invested in Bio-Techne in 2024 Q3 according to their latest regulatory filings, with 58 funds opening new positions, 193 increasing their positions, 211 reducing their positions, and 62 closing their positions.
262% more call options, than puts
Call options by funds: $16.9M | Put options by funds: $4.67M
150% more funds holding in top 10
Funds holding in top 10: 4 → 10 (+6)
11% more capital invested
Capital invested by funds: $11.2B → $12.4B (+$1.19B)
6% less first-time investments, than exits
New positions opened: 58 | Existing positions closed: 62
9% less repeat investments, than reductions
Existing positions increased: 193 | Existing positions reduced: 211
1.44% less ownership
Funds ownership: 98.94% → 97.5% (-1.4%)
2% less funds holding
Funds holding: 572 → 562 (-10)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Point72 Asset Management
Stamford,
Connecticut
|
+$84.3M |
| 2 |
Citadel Advisors
Miami,
Florida
|
+$71.1M |
| 3 |
T. Rowe Price Associates
Baltimore,
Maryland
|
+$67.5M |
| 4 |
Adage Capital Partners
Boston,
Massachusetts
|
+$24.3M |
| 5 |
Invesco
Atlanta,
Georgia
|
+$23.4M |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
BlackRock
New York
|
-$86.3M |
| 2 |
Select Equity Group
New York
|
-$50.8M |
| 3 |
ACH
ArrowMark Colorado Holdings
Denver,
Colorado
|
-$39.2M |
| 4 |
Allspring Global Investments
Charlotte,
North Carolina
|
-$30.8M |
| 5 |
BAMCO Inc
New York
|
-$24.9M |
TECH Hedge Fund Activity: Q3 2024 in Review
562 of the 6,978 institutional investors tracked by Wall St. Rank reported a position in Bio-Techne (TECH) for Q3 2024, worth a combined $12.4B — up 11% from $11.2B a quarter earlier.
Sellers outnumbered buyers: 62 funds closed out of TECH and 58 opened new positions — a net loss of 4 holders — while 211 trimmed existing stakes and 193 added.
The largest buyer was Point72 Asset Management, opening a new position worth an estimated $84.3M. The largest seller was BlackRock, cutting an estimated $86.3M.
- 562 institutional investors held Bio-Techne (TECH) as of Q3 2024, down from 572 in Q2 2024.
- Funds reported $12.4B of Bio-Techne stock for Q3 2024, up 11% quarter-over-quarter.
- 58 funds opened new Bio-Techne positions in Q3 2024 and 62 closed out, a net change of -4 holders.
- The largest Bio-Techne buyer in Q3 2024 was Point72 Asset Management, an estimated $84.3M added.
- The largest Bio-Techne seller in Q3 2024 was BlackRock, an estimated $86.3M sold.
Based on aggregated 13F filings for Q3 2024.